Adalimumab-induced optic neuropathy in a patient with Behçet’s syndrome by Sofia Miranda, Daniel Calado, Joana Rua, Fernando Salvador

Subjects: “…adalimumab…”
Get full text

Tuberculosis of the tongue in a patient under treatment with adalimumab by Cintia Mussi Milani, Rafaela Arana, Rafaela Sávio Melzer, Antônio Adilson Soares Lima, Maria Angela Naval Machado, Liliane Roskamp

Subjects: “…adalimumab…”
Get full text

Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs by Anna Pau, Ilaria Galliano, Elisa Barnini, Maddalena Dini, Antonio Pizzol, Alice Ponte, Stefano Gambarino, Pier Luigi Calvo, Massimiliano Bergallo

Subjects: Get full text

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease by Edyta Szymanska, Maciej Dadalski, Wieslawa Grajkowska, Sylwia Szymanska, Maciej Pronicki, Jaroslaw Kierkus

Subjects: “…adalimumab…”
Get full text

Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells by Dana Emerson, Eve Merriman, Pia P. Yachi

Subjects: Get full text

Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid by Kyohei Shibuta, Koremasa Hayama, Katsuhiro Miura, Hideki Fujita

Subjects: Get full text

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the... by Selma Atalay, Sophie E. Berends, Hans M. M. Groenewoud, Ron A. A. Mathot, David M. Njoo, Johannes M. Mommers, Paul M. Ossenkoppele, Marjolein I. A. Koetsier, Maartje A. Berends, Annick de Vries, Peter C. M. van de Kerkhof, Alfons A. den Broeder, Elke M. G. J. de Jong, Juul M. P. A. van den Reek

Subjects: Get full text

Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review by Erin Balay-Dustrude, Jessica Fennell, Kevin Baszis, Y. Ingrid Goh, Daniel B. Horton, Tzielan Lee, Chloe Rotman, Anna Sutton, Marinka Twilt, Olha Halyabar, for the CARRA JIA Inactive Disease Workgroup

Subjects: “…Adalimumab…”
Get full text

Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience by Marcin Sochal, Monika Krzywdzińska, Agata Gabryelska, Renata Talar-Wojnarowska, Ewa Małecka-Panas

Subjects: Get full text

Successful Treatment of Annular Atrophic Lichen Planus With Adalimumab by Joe Khodeir, Paul Ohanian, Marielena Ohanian

Subjects: “…adalimumab…”
Get full text

The Efficacy of Adalimumab Treatment in Pediatric Non-Infectious Uveitis: A Retrospective Cohort Study by Kübra Özdemir Yalçınsoy, Osman Özen, Yasemin Özdamar Erol, Pınar Çakar Özdal

Subjects: Get full text

Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation by Chunbo Zhang, Xiaorong Xue, Jinan Xiao, Qiongge Li, Yuyao Zhai, Ying Chen

Subjects: Get full text

Size exclusion chromatography as green support for forced degradation study of adalimumab by Kovačić Jelena, Klarić Daniela Amidžić, Turk Nikša, Mornar Ana

Subjects: Get full text

Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings by Fang Qiu, Weiquan Chen, Ying Zhou

Subjects: Get full text

Efficacy of adalimumab for Hailey-Hailey disease demonstrated by reduction of the Pemphigus Disease Area Index by Madeleine Stark, MChD, Tabrez Sheriff, MBBS, Dédée F. Murrell, MA, BMBCh, MD, DSc

Subjects: “…adalimumab…”
Get full text

Therapeutic drug monitoring and neutralizing anti-drug antibody detection to optimize TNF-alpha inhibitor treatment for uveitis by Howard C. Chen, Jenny Shunyakova, Amit K. Reddy, Srujay Pandiri, Lynn Hassman

Subjects: Get full text

Case report: dysgeusia, strawberry tongue, and psoriatic eruptions after combination treatment with adalimumab, sulfasalazine, and etoricoxib for ankylosing spondylitis by Binglin Cui, Jing Lin, Yuanchun Huang, Huachen Zhu, Huachen Zhu, Huachen Zhu, Jinbo Zou, Jiesheng Qin, Hui Pan, Hui Pan, Jian Chen

Subjects: Get full text

Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity by Aboli Bhingarkar, Yuyin Wang, Keito Hoshitsuki, Katherine Marie Eichinger, Katherine Marie Eichinger, Sanjay Rathod, Yin Zhu, He Lyu, Andrew T. McNutt, Larry W. Moreland, Lee McDermott, David R. Koes, Christian A. Fernandez

Subjects: Get full text

Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy by A. I. Khavkin, A. V. Nalyotov, N. A. Marchenko

Subjects: Get full text

Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice by Dorota Waz, Michał Mazur, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Wiktoria Tabin-Barczak, Aldona Sokołowska, Klaudia Fikas, Kamil Chwaliszewski, Sebastian Samuła

Subjects: “…adalimumab…”
Get full text